BRCA1 requirement for the fidelity of plasmid DNA double‐strand break repair in cultured breast epithelial cells

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Environmental and Molecular Mutagenesis

• Publication date

  2012-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/em.21674PMID 22170030
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis-dependent microhomology-mediated end joining accounts for multiple types of repair junctions

  2010cited by this paper
• The CHK2–BRCA1 tumour suppressor pathway ensures chromosomal stability in human somatic cells

  2010cited by this paper
• ATM regulates Mre11-dependent DNA end-degradation and microhomology-mediated end joining

  2010cited by this paper
• Estrogen Receptor α Enhances the Rate of Oxidative DNA Damage by Targeting an Equine Estrogen Catechol Metabolite to the Nucleus*

  2009cited by this paper
• CtIP-BRCA1 modulates the choice of DNA double-strand break repair pathway throughout the cell cycle

  2009influential reference
• Corrected structure of mirin, a small-molecule inhibitor of the Mre11-Rad50-Nbs1 complex.

  2009cited by this paper
• Limiting the Persistence of a Chromosome Break Diminishes Its Mutagenic Potential

  2009cited by this paper
• A forward chemical genetic screen reveals an inhibitor of the Mre11-Rad50-Nbs1 complex.

  2008cited by this paper
• Mre11 dimers coordinate DNA end bridging and nuclease processing in double-strand-break repair.

  2008cited by this paper
• MMEJ repair of double-strand breaks (director's cut): deleted sequences and alternative endings.

  2008cited by this paper
• Involvement of Ku80 in microhomology-mediated end joining for DNA double-strand breaks in vivo.

  2007cited by this paper
• Checkpoint kinase 2-mediated phosphorylation of BRCA1 regulates the fidelity of nonhomologous end-joining.

  2006influential reference
• Ataxia telangiectasia mutated and checkpoint kinase 2 regulate BRCA1 to promote the fidelity of DNA end-joining.

  2006cited by this paper
• Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention.

  2006cited by this paper
• Good Timing in the Cell Cycle for Precise DNA Repair by BRCA1

  2005cited by this paper
• A rapid in vitro polyomavirus DNA replication assay.

  2004cited by this paper
• Fidelity of DNA double-strand break repair in heterozygous cell lines harbouring BRCA1 missense mutations

  2004influential reference
• Impact of the KU80 pathway on NHEJ-induced genome rearrangements in mammalian cells.

  2004influential reference
• Breast Cancer Risk and the DNA Double-Strand Break End-Joining Capacity of Nonhomologous End-Joining Genes Are Affected by BRCA1

  2004influential reference
• The role of BRCA1 in the cellular response to chemotherapy.

  2004cited by this paper
• BRCA1 and BRCA2: 1994 and beyond

  2004cited by this paper
• Mutation screening of Mre11 complex genes: indication of RAD50 involvement in breast and ovarian cancer susceptibility

  2003cited by this paper
• Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility.

  2003cited by this paper
• Nonhomologous end joining and V(D)J recombination require an additional factor

  2003cited by this paper
• BRCA1 Facilitates Microhomology-mediated End Joining of DNA Double Strand Breaks*

  2002influential reference
• Absence of major defects in non-homologous DNA end joining in human breast cancer cell lines

  2002cited by this paper
• A single mutated BRCA1 allele leads to impaired fidelity of double strand break end-joining

  2002influential reference
• Deficient nonhomologous end-joining activity in cell-free extracts from Brca1-null fibroblasts.

  2002influential reference
• Homology-directed dna repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation.

  2001cited by this paper
• Structural biochemistry and interaction architecture of the DNA double-strand break repair Mre11 nuclease and Rad50-ATPase.

  2001cited by this paper
• Nonhomologous end-joining of ionizing radiation-induced DNA double-stranded breaks in human tumor cells deficient in BRCA1 or BRCA2.

  2001influential reference
• Direct DNA binding by Brca1

  2001cited by this paper
• A mechanistic basis for Mre11-directed DNA joining at microhomologies.

  2000cited by this paper
• BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures.

  2000cited by this paper
• BRCA1 deficient embryonic stem cells display a decreased homologous recombination frequency and an increased frequency of non-homologous recombination that is corrected by expression of a Brca1 transgene

  1999cited by this paper
• Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response.

  1999cited by this paper
• Genetic analysis of BRCA1 function in a defined tumor cell line.

  1999cited by this paper
• The 3' to 5' exonuclease activity of Mre 11 facilitates repair of DNA double-strand breaks.

  1998cited by this paper
• Association of BRCA1 with Rad51 in mitotic and meiotic cells.

  1997cited by this paper
• Isolation and characterization of the human MRE11 homologue.

  1995cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer

  1994cited by this paper

• Microhomology‐mediated repair machinery and its relationship with HPV‐mediated oncogenesis

  2024cites this paper
• Evaluation of DNA double-strand break repair capacity in human cells: Critical overview of current functional methods.

  2021cites this paper
• A new view of the mammary epithelial hierarchy and its implications for breast cancer initiation and metastasis.

  2019cites this paper
• Long-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenografts

  2018cites this paper
• Unsolved mystery: the role of BRCA1 in DNA end-joining

  2016influential citation
• Chemical Inhibitors of Non-Homologous End Joining Increase Targeted Construct Integration in Cryptococcus neoformans

  2016cites this paper
• Breast cancer predisposition gene brca1, pathogenic c61g mutation in mice: synthetic viability in DNA repair and tumour development

  2016cites this paper
• A role for human homologous recombination factors in suppressing microhomology-mediated end joining

  2016cites this paper
• Aberrant recombination and repair during immunoglobulin class switching in BRCA1-deficient human B cells

  2015cites this paper
• MOLECULAR MECHANISMS OF ANTIBODY DIVERSIFICATION IN HUMAN B-CELLS

  2015cites this paper
• Complex-based analysis of dysregulated cellular processes in cancer

  2014cites this paper
• Repair of chromosomal double-strand breaks by precise ligation in human cells.

  2013cites this paper
• The role of BRCA1 in homologous recombination repair in response to replication stress: significance in tumorigenesis and cancer therapy

  2013cites this paper
• Expression of human BRCA1Δ17-19 alternative splicing variant with a truncated BRCT domain in MCF-7 cells results in impaired assembly of DNA repair complexes and aberrant DNA damage response.

  2013cites this paper
• BRCA1-Ku80 Protein Interaction Enhances End-joining Fidelity of Chromosomal Double-strand Breaks in the G1 Phase of the Cell Cycle*

  2013cites this paper